Last updated on August 2018

Long-term Open-label Multicenter Study Assessing Long-term Cardiovascular Risks in Patients Treated With Fingolimod


Brief description of study

This study will evaluate if patients who had a serious cardiovascular event upon initiation of fingolimod are at risk to delevop long term other cardiovascular events

Clinical Study Identifier: NCT02232061

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Verviers, Belgium
0.3miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.